Home › Depression › Alabama
Depression clinical trials in Alabama
14 studies for Depression are looking for participants at sites in Alabama.
Cities in Alabama
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- UAB Psychiatry and Behavioral Neurology, Birmingham
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Nov 13, 2026 · NCT06793397Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- University of Alabama Birmingham Hospital, Birmingham
Recruiting
Ages 12 to 22 · All sexes · Updated Nov 13, 2026 · NCT06232304RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 10, 2026 · NCT07002034A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Center, Huntsville
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT03887715A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- University of Alabama at Birmingham - School of Medicine, Birmingham
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 3, 2026 · NCT07775300Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Huntsville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT06966401Digital Intervention for Physical Activity
- Kinesiology Building, Auburn
Recruiting
Ages 19 to 40 · All sexes · Updated Oct 28, 2026 · NCT07130734Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
- Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 23, 2026 · NCT07226232NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Huntsville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT06911112Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Campus, Huntsville
RecruitingHealthy volunteers welcome
Ages 10 to 24 · All sexes · Updated Jul 13, 2026 · NCT05437588Investigating Dynamic Interactions in Distributed Cognitive Control Networks
- University of Alabama at Birmingham, Birmingham
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 29, 2026 · NCT05927974Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
- University of South Alabama, Mobile
Recruiting
Ages 19 to 65 · All sexes · Updated Apr 6, 2026 · NCT06467695MicroRNA Correlates of Childhood Maltreatment and Suicidality
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Campus, Huntsville
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 60 · All sexes · Updated Mar 30, 2026 · NCT04923685Strengthening Health and Insight in New Educators
- University of Alabama, Tuscaloosa
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 2, 2025 · NCT06745934From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.